Search
for
Sort by
Research 421–450 of 1000+
- Trichoscopic evaluation of dental pulp stem cell conditioned media for androgenic alopecia.
- Low-level Laser Therapy with Novel Array of Light Source and Individualized Program for Treatment of Androgenetic Alopecia: A 16-week, Randomized, Double-blind, Sham Device-controlled Study
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- A comparative study of microneedling with platelet-rich plasma plus topical minoxidil (5%) and topical minoxidil (5%) alone in androgenetic alopecia
- Is androgenetic alopecia a risk for atherosclerosis?
- Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial
- Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation
- The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia
- Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults
- Progressive expression of PPARGC1α is associated with hair miniaturization in androgenetic alopecia
- Association of androgenetic alopecia and severity of coronavirus disease 2019
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Comparing the therapeutic efficacy of topical minoxidil and finasteride with topical minoxidil and oral finasteride in androgenetic alopecia: a randomized trial
- Genetic prediction of male pattern baldness based on large independent datasets
- Androgenetic alopecia and COVID‐19: Is there a clinical connection?
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- An anti‐hair loss treatment in the management of mild androgenetic alopecia: results from a large, international observational study
- The Use of Botulinum Toxin in the Treatment of Androgenetic Alopecia: A Systematic Review
- Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Early Onset Male Androgenetic Alopecia - A Cross Sectional Study in a Tertiary Care Hospital
- Association Between Smoking and Androgenetic Alopecia: A Cross-Sectional Analysis of Severity and Dose-Response Relationship in Adult Males
- [Translated article] High-dose Oral Minoxidil for the Treatment of Androgenetic Alopecia
- COMPARITIVE STUDY OF TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) VERSUS PLATELET-RICH PLASMA PLUS TOPICAL MINOXIDIL (5%) PLUS FINASTERIDE (0.1%) IN PATIENTS WITH ANDROGENIC ALOPECIA
- Correlation of Trichoscopic Findings with Severity in Androgenetic Alopecia
- Rose stem cell‐derived exosomes for hair regeneration enhancement via noninvasive electroporation in androgenetic alopecia
- TH07-A New Novel Topical Treatment for Androgenic Alopecia
- Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
- Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Supplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer